SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Induce at 41 weeks, RCT finds
Thurs Nov 21st - Inducing labour at 41 weeks of gestation is significantly safer than waiting another week, according to the findings of a major Swedish randomised study published today. More
RECENT COMMENTS
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
BOOKS ON WOMEN'S HEALTH
guide to breast disorders guide to womb disorders guide to menopause Complete Women's Health: from The Royal College of Obstetricians and Gynaecologists For books and family gift ideas click here
OTHER NEWS OF INTEREST
WOMEN'S HEALTH NEWS FEED
RSS graphic XML Graphic
ENGLEMED HEALTH NEWS

Improved breast cancer relapse test unveiled

Wednesday March 21st, 2018

Breast cancer patients with the BRCA mutation and an increased risk of relapse can be identified by testing for other genetic variants, a European conference will hear today.

Techniques already exist to test for low risk genetic variants linked to breast cancer. They can be used effectively to highlight relapse risk for BRCA mutation carriers, say Dr Alexandra van den Broek from the Netherlands Cancer Institute in Amsterdam, the Netherlands, and her team.

The research was being presented today (21 March) at the 11th European Breast Cancer Conference in Barcelona, Spain.

An analysis of about 6,000 breast cancer patients was able to separate out which women with BRCA-related breast cancer have the lowest rate of recurrences and which women have the highest.

This could improve treatment decisions, they believe.

Dr van den Broek said: "Women with a BRCA mutation are more likely to develop breast cancer when they are young and, unfortunately, some will be unlucky and go on to suffer a second breast cancer later in life. We know these women are at a higher risk, but it has also been shown that individual risks may vary widely, so we wanted to see if there was any way to better identify patients at lower and higher risks.

"These polygenic risk scores were originally developed to try to better predict the risk of developing a first breast cancer. Our research suggests that they can also be used to help patients who have survived their first breast cancer to better understand their level of risk for a second breast cancer.

“We hope these findings will add to the existing knowledge about predicting risk for a second breast cancer in these survivors."

Abstract no: 7, The association between Polygenic Risk Scores and contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: analyses in the CIMBA consortium, was presented on 21 March at the Clinical Science Symposium: Risk Modelling session, of the 11th European Breast Cancer Conference in Barcelona, Spain.

Tags: Cancer | Europe | Women's Health & Gynaecology

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES